Two spin-labelled derivatives of the 5-(2-indolyl)-2,4-pentadienoyl class of inhibitors of the vacuolar ATPase have been synthesised and their EPR properties characterised in phospholipid membranes. One spin-labelled inhibitor is the amide derivative of pentadienic acid and 4-amino-TEMPO (INDOL6), and the other is the 3-hydroxymethyl-PROXYL ester (INDOL5). The response of the EPR spectra to the chainmelting transition of dimyristoyl phosphatidylcholine (DMPC) bilayers demonstrates that both derivatives incorporate in phospholipid membranes. The axially anisotropic EPR spectra of INDOL6 in fluid DMPC membranes indicate that the indolyl-pentadienoyl inhibitors intercalate between the lipid chains, in the membrane. INDOL5, designed to possess additional internal segmental mobility, exhibits more nearly isotropic motion of the spin-label moiety in fluid membranes than does INDOL6. The EPR characteristics of INDOL5 are therefore well suited to detecting specific ligand-protein interactions. Progressive saturation EPR experiments with polar and hydrophobic relaxation agents (aqueous Ni 2+ and oxygen) show that the nitroxide group is buried in the membrane, with the indole moiety providing the anchor at the membrane polar-apolar interface. Rates of spin-label reduction by externally added ascorbate confirm this assignment. These two spinlabelled derivatives provide complementary EPR probes of the lipid environment (INDOL6), and of ligand-protein interactions (INDOL5), for this class of V-ATPase inhibitor. D
Introduction
Inhibition of the osteoclast variant of the vacuolar ATPase (V-ATPase) potentially provides a therapeutic strategy to combat bone resorption in osteoporosis. Of the 5-(2-indolyl)-2,4-pentadienoyl family of inhibitors, the 1,2,2,6,6-pentamethyl-piperidin-4-yl derivative shown in Fig. 1 (INDOL0) has an IC 50 of 29 nM for inhibition of the V-ATPase in chicken osteoclasts, and exhibits a selectivity for the osteoclast enzyme over other V-ATPases [1] . To serve as a spin-label EPR reporter of the membrane environment and site of action for this class of inhibitor, we have synthesised INDOL6, the nitroxyl variant of INDOL0 [2] . Subsequent EPR analysis shows INDOL6 to be highly ordered in fluid lipid membranes, and led to the synthesis of a complementary derivative, INDOL5. The latter spin label was designed to possess additional internal molecular rotational freedom, compared with INDOL6, and hence to be better suited to the detection of inhibitor ligand-protein interactions.
In the present paper, we describe the EPR properties of the two spin-labelled inhibitors in phospholipid bilayer membranes of dimyristoyl phosphatidylcholine (DMPC). Spectral line shapes are used to deduce the mode of insertion of the inhibitor in the membrane. Relaxation enhancement agents are used to localise the spin label group within the bilayer. Chemical reduction by aqueous ascorbate is further used to determine penetration depth and directionality of insertion. This study characterises the ordering, orientation, location and mobility of the indolylpentadienoyl inhibitors in the lipid milieu of biological membranes. It therefore provides the requisite background for use of these 
Materials and methods

Materials
DMPC was obtained from Avanti Polar Lipids (Alabaster, AL). Spin-labelled phosphatidylcholines n-PCSL (1-acyl-2-[n-(4,4-dimethyloxazolidine-N-oxyl)]stearoyl-sn-glycero-3-phosphocholine) were synthesised as described in Ref. [3] . Spin-labelled cholestane (3-spiro-[2V-(4V,4V-dimethyloxazolidine-N-oxyl)]-cholestane, CSL) was obtained from Syva (Palo Alto, CA). HEPES buffer and sodium ascorbate were from Sigma Chemical Co. (St. Louis, MO). (2Z,4E)-5-(5,6-Dichloro-2-indolyl)-2-methoxy-2,4-pentadienoic acid [4] (100 mg, 0.32 mmol), 1-hydroxybenzotriazole (48 mg, 1.1 eq), and N-[3-(dimethylamino)-Nethylcarbodiimide hydrochloride (68 mg, 1.1 eq) dissolved in CH 3 CN (3 ml) and tetrahydrofuran (THF; 1 ml) were heated at 40 8C under N 2 for 1 h. After which, the mixture was warmed to 60 8C, 4-amino-2,2,6,6-tetramethylpiperidinoxy free radical (66 mg, 1.2 eq) was added, and then refluxed for 1 h. After cooling, the solvent was removed under reduced pressure, the residue treated with 10% NaOH, extracted (EtOAc), dried (MgSO 4 ), and concentrated to give the crude product. The latter was purified by flash column chromatography, eluted with EtOAc/Petrol (7:3), to give (2Z,4E)-5-(5,6-dichloro-2-indolyl)-2-methoxy-N-[4-(2,2,6,6-tetramethylpiperidinoxy]-2,4-pentadienamide (118 mg, 79%). (Full characterisation is reported in Ref. [2] .) The IC 50 of INDOL6 for inhibition of yeast V-ATPase is ca. 10-30 AM, as compared with ca. 3 AM for the parent compound INDOL0.
INDOL5
SOCl 2 (58 Al, 2.5 eq) was added to a suspension of 5-(5,6-dichloro-2-indolyl)-2-methoxy-2,4-pentadienoic acid (99 mg, 0.317 mmol) in THF (15 ml) and heated under reflux for 2 h, allowed to cool, and solvents removed under reduced pressure to give a green crystalline solid. This was dissolved in THF (3 ml) and treated with 1-oxyl-2,2,5,5-tetramethyl-3-hydroxy-methylpyrrolidine (15 mg, 0.35 eq), dimethylaminopyridine (38 mg, 0.3 eq), stirred at room temperature for 7 h, and then heated under reflux for 3 h. The reaction was allowed to cool to room temperature, diluted with CH 2 Cl 2 , washed with sat. NaHCO 3 solution (3 ml) and extracted with CH 2 Cl 2 (3Â15 ml). The combined organics were dried (MgSO 4 ) and concentrated under reduced pressure to give the crude product, which was purified by flash column chromatography (EtOAc/Petrol, 1:1) to give a dark green crystalline solid (19 mg, 47%). Analysis by electro-spray mass spectrometry showed the major peak at M + +35, presumably arising from HCl addition to the desired ester product. (For full characterisation, see Ref. [5] ).
Sample preparation
Lipid (ca. 1 mg) and spin label (at a relative concentration of b1 mol%) were codissolved in dichloromethane or chloroform-methanol. The solution was dried down in a nitrogen gas stream, and traces of the residual solvent were removed by evacuating overnight. The dry lipid was suspended in 50 Al of 40 mM HEPES, pH 7.0 buffer by vortexing at a temperature above the chain-melting transition of 24 8C. The lipid dispersion was then filled into a 50-Al, 1-mm i.d., glass capillary, and concentrated by pelletting in a benchtop centrifuge at 3000 rpm for 15 min. Excess supernatant was removed, the sample trimmed to 5-mm length, and the capillary was flame-sealed. For samples used in progressive saturation experiments, buffers and lipid dispersions were saturated with either argon or oxygen, and the sample capillaries were flushed with either argon or oxygen, as required.
For experiments to determine the rate of spin-label reduction by ascorbate, lipid dispersions were not centrifuged. The reaction was initiated by adding ascorbate from a concentrated stock solution to the lipid dispersion in the sample capillary, mixing, and then transferring the capillary immediately to the spectrometer. 
EPR spectroscopy
EPR spectra were recorded on a Bruker EMX 9-GHz spectrometer, equipped with nitrogen gas-flow temperature regulation. Sample capillaries were accommodated in standard quartz EPR tubes which contained light silicone oil for thermal stability. Samples, 5 mm in length, were centred in the rectangular cavity resonator. Temperature was monitored by a fine-wire thermocouple situated in the silicone oil at the top of the EPR resonator. Progressive saturation experiments were performed by recording the conventional firstharmonic in-phase spectrum (V 1 -display) as a function of the incident microwave H 1 -field at the sample. Calibration of the H 1 -field and correction for inhomogeneities were performed as described in Ref. [6] .
Results and discussion
Spectra of INDOL6 and INDOL5 in DMPC membranes
The characteristic sensitivity of spin-label EPR spectra to membrane dynamics [7] allows information on the membrane environment of the nitroxide-labelled V-ATPase inhibitors to be obtained from the EPR line shapes. Fig. 2 gives the EPR spectra of INDOL6, the shorter amide-linked, piperidine nitroxide derivative of the indolyl inhibitor, in bilayer membranes of DMPC. At low temperature, e.g., 6 8C, the spectra correspond to a strongly immobilised spin label, although not completely at the rigid limit. This is characteristic of the ordered gel-state of lipid bilayer membranes. At around 25 8C, the total spectral extent decreases considerably, as a result of (partial) motional averaging in response to the chain-melting transition of the DMPC bilayers. In the fluid state, above the phase transition, the EPR spectra of INDOL6 still possess considerable residual anisotropy. They do not approximate to a sharp, three-line isotropic hyperfine spectrum. This spectral anisotropy indicates that the INDOL6 molecule is oriented by the fluid lipid chains, with relatively little internal segmental motion. Both the ordering of INDOL6 in the fluid, liquid-crystalline phase of the lipid membrane and the cooperative response to the phase transition (see Fig. 3 ) indicate that the spin-labelled indolyl derivative is intercalated between the lipid chains of the membrane. Fig. 4 gives the EPR spectra of INDOL5, the longer, ester-linked pyrrolidine nitroxide derivative, in DMPC bilayer membranes. The spectra of INDOL5 in the gel phase at low temperature (e.g., 6 8C) are again indicative of strong immobilisation, but not quite to the same extent as for INDOL6. At the chain-melting transition, around 25 8C (see Fig. 3 ), the spectra of INDOL5 narrow considerably-much more so than do those of INDOL6. Above the phase transition, in the fluid membrane phase, the spectra of INDOL5 rapidly come to approximate an isotropic, three-line spectrum with relatively narrow hyperfine lines, although these remain differentially broadened. This contrasts with the behaviour of INDOL6 in the fluid phase, where its amplitude of rotation is still limited anisotropically. The difference in rotational freedom of the spin label group between the INDOL6 and INDOL5 derivatives in fluid membranes must be attributed to the additional single bond in the link between the nitroxide ring and indolyl conjugated system. Thus, the enhanced rotational freedom of INDOL5 arises from increased segmental motion within the molecule. These contrasting spectral properties of the two indolyl-pentadienoyl derivatives furnish complementary probes of the membrane environment of the V-ATPase inhibitor. By virtue of its pronounced spectral anisotropy, INDOL6 is expected to be extremely sensitive to the nature of the lipid membrane environment in which the inhibitor is situated. On the other hand, INDOL5 has a rather narrow isotropic spectrum in fluid lipid membranes. This offers the opportunity of detecting specific ligand-protein interactions with INDOL5, by resolving a second immobilised spectral component. The latter situation is similar to the direct detection of lipid-protein interactions by using lipids spinlabelled close to the chain terminal methyl group [8] .
Environmental polarity
The isotropic hyperfine splitting of the nitroxide, a o N , is unaffected by molecular motion, but is sensitive to environmental polarity and to hydrogen bonding (e.g., to water)-see, e.g., Ref. [7] . The values of a o N for INDOL6 and INDOL5 in solvents of different polarity and H-bonding capacity are given in Table 1 . These values are determined simply from the baseline-crossing points of the firstderivative EPR spectra in these isotropic, non-viscous solvents. For both spin labels, the isotropic hyperfine splittings decrease from the highly polar, hydrogen-bonding solvent water (dielectric constant=80) to the apolar, aprotic solvent chloroform (dielectric constant=5). Those in a CHCl 3 The value of a o N for INDOL5 in DMPC bilayer membranes can be obtained from the baseline crossings in the symmetrical, isotropic, three-line, EPR spectra recorded at high temperature (see Fig. 4 ). The spectra of INDOL6 in DMPC bilayer membranes remain anisotropic, but of axial symmetry, even up to high temperatures (see Fig. 2 ). In this latter case, the value of a o N was obtained from the isotropic average: a o N =1/3(A // +2A 8 ). Here A // and A 8 are the outer and inner hyperfine splittings that correspond to magnetic field orientations parallel and perpendicular, respectively, to the symmetry axis (i.e., to the membrane normal). Measurements were made at sufficiently high temperatures to ensure that the values of a o N were independent of temperature, i.e., free of artifacts from slow motion. It is seen from Table 1 that the values of a o N for INDOL6 and INDOL5 lie between the values in water and in the hydrophobic solvent chloroform. Both correspond to an effective environmental polarity that is similar to that in CHCl 3 /MeOH (2:1 v/v). This indicates that the nitroxide group of INDOL6 and INDOL5 is not exposed directly to water but is buried within the membrane, at least partially. 
Accessibility to polar and hydrophobic relaxation agents
As discussed in the previous sections, the EPR line shapes demonstrate that the indolyl-pentadienoyl inhibitors intercalate and are ordered between the lipid chains. To determine the vertical location of the inhibitors in the membrane and, indeed, the directionality of insertion into the membrane, it is necessary to locate the position of the spin-label nitroxyl moiety in the membrane. In this section, we describe experiments with a relaxation agent that is confined essentially to the aqueous phase (NiSO 4 ), and a hydrophobic relaxant (molecular oxygen) that concentrates in the interior of the membrane (see, e.g., Ref. [9] ). Fig. 5 shows saturation curves for the amplitude of the central line in the EPR spectra of INDOL6 and INDOL5 in DMPC, as a function of increasing intensity of the H 1 -microwave field. Saturation curves are given for samples in the absence (i.e., argon-saturated) and in the presence of the paramagnetic relaxation agents: either saturated with molecular oxygen or in 30 mM NiSO 4 saturated with argon. The alleviation of saturation of the spin-label amplitude at high H 1 -field in the presence of the relaxation agents is clearly evident in Fig. 5 . Oxygen is more effective than NiSO 4 in inducing relaxation enhancement. This suggests immediately that the nitroxide groups of INDOL6 and INDOL5 are located in the hydrophobic interior of the membrane.
The solid lines in Fig. 5 represent nonlinear least-squares fits of the following dependence of the spectral amplitude, A, on H 1 -field:
where c e is the electron gyromagnetic ratio, T 1 is the spinlattice relaxation time, and T 2 is the transverse (or spinspin) relaxation time. It is assumed that e=1.5 for the central EPR amplitude in the fitting (which corresponds to purely Lorentzian line shapes), because the data are not sufficiently precise to use e as a fitting parameter (see, e.g., Ref. [10] ). From the fits it is possible to obtain values for the composite T 1 T 2 relaxation time product (see, e.g., Ref. [11] ). Fig. 6 shows the relaxation rate enhancements obtained for the 5-PCSL and 14-PCSL spin labels in DMPC membranes, where the spin label group is on the n=5 or n=14 C-atom in the sn-2 chain of phosphatidylcholine. Horizontal bars in Fig. 6 indicate the corresponding corrected relaxation enhancements for the INDOL6 and INDOL5 inhibitors. Although there is some scatter in the data from the two labels, and between fluid and gel-phase membranes, the results of Fig. 6 indicate very clearly that nitroxide groups of both indolyl inhibitors, INDOL6 and INDOL5, are located in the hydrocarbon interior of the membrane. This implies that both nitroxyl derivatives are anchored in the membrane with their indole groups at the polar-apolar interface of the membrane, and the nitroxide ring directed inwards. This is in agreement with the interfacial location of numerous tryptophan side-chain indoles in transmembrane proteins [12, 13] and small peptides [14] , as well as several indole-containing amphiphiles [15] .
Reduction of membrane-bound INDOL5 and INDOL6 by ascorbate
The rates of chemical reaction of membrane-embedded spin labels by ascorbate permeating from the aqueous phase afford a means for determining the insertion depth of the spin label in the membrane [16] . Fig. 7 gives decay curves of the EPR amplitude for the INDOL5 derivative, and various spinlabelled lipids, on addition of 10 mM ascorbate to the membrane suspensions. The decays are exponential with a pseudo first-order rate constant of k 1 eff =k 2 [asc] o , where k 2 is the second-order rate constant and [asc] o is the constant concentration of ascorbate in the aqueous phase. For the spinlabelled lipids, the dependence of the decay rate on depth in the membrane is clearly evident. The fastest decay is for spinlabelled cholestane (CSL), where the nitroxide group is located at the membrane-water interface (i.e., nu0). Fig. 8 gives the half-times for reduction of the different spin-labelled lipids in DMPC membranes in the presence of 10 mM ascorbate. To compare with the corresponding values for the INDOL6 and INDOL5 spin labels, it is necessary to correct for the differences in reactivity with ascorbate of the different nitroxide moieties. The sixmembered piperidine ring nitroxides are reduced much more rapidly than are the five-membered pyrrolidine ring nitroxides [17] and the oxazolidine nitroxides are intermediate. For this reason, intrinsic rates of reduction of the different spin labels were determined in CHCl 3 /MeOH (2:1 v/v) solutions that were treated with 5 mM ascorbate. Measured rates were then extrapolated to 10 mM ascorbate.
The corrected half-times of reduction for INDOL6 and INDOL5 in DMPC membranes are given by the horizontal bars in Fig. 8 . Relative to the spin-labelled lipids, the corrected reduction rate of INDOL6 is below that of 5-PCSL, whereas that of INDOL5 is closer to the value for 5-PCSL, i.e., deeper in the membrane. This result is consistent with the conclusions reached from measurements with paramagnetic relaxants, i.e., that the nitroxide groups of INDOL6 and INDOL5 are in the hydrocarbon interior of the membrane, with the indole group anchored at the polar-apolar interface.
Conclusions
The 5-(2-indolyl)-2,4-dienoyl V-ATPase inhibitors insert into the bilayer regions of membranes, intercalated between the lipid chains. The nitroxide rings of the spin-labelled derivatives are buried within the hydrophobic interior of the membrane, and the indole moiety is anchored at the polarapolar interface. The INDOL6 EPR-probe reports sensitively on the fluid lipid environment of the inhibitor, whereas the INDOL5 probe allows direct detection of inhibitor-protein interactions within the membrane.
